Healthpeak Properties (NYSE:DOC) Updates FY 2026 Earnings Guidance

Healthpeak Properties (NYSE:DOC) updated its FY 2026 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 1.730-1.770 for the period, compared to the consensus estimate of 1.750. The company issued revenue guidance of -.

Analyst Ratings Changes

A number of brokerages have issued reports on DOC. Weiss Ratings raised Healthpeak Properties from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, May 8th. BMO Capital Markets upped their target price on shares of Healthpeak Properties from $20.00 to $24.00 and gave the stock an “outperform” rating in a report on Monday, June 15th. Scotiabank increased their target price on shares of Healthpeak Properties from $19.00 to $21.00 and gave the stock a “sector perform” rating in a research report on Wednesday, May 27th. JPMorgan Chase & Co. lifted their price target on shares of Healthpeak Properties from $18.00 to $21.00 and gave the company a “neutral” rating in a report on Wednesday, June 24th. Finally, Mizuho boosted their price target on shares of Healthpeak Properties from $21.00 to $24.00 and gave the company an “outperform” rating in a research report on Monday, July 6th. Four investment analysts have rated the stock with a Buy rating and fifteen have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $20.62.

Healthpeak Properties Price Performance

Healthpeak Properties stock traded down $0.05 on Tuesday, reaching $21.59. The company’s stock had a trading volume of 7,351,954 shares, compared to its average volume of 8,641,072. The company has a debt-to-equity ratio of 1.15, a quick ratio of 2.96 and a current ratio of 2.96. The company has a market cap of $14.89 billion, a price-to-earnings ratio of 67.48, a PEG ratio of 3.39 and a beta of 1.02. The business’s fifty day moving average price is $21.05 and its 200 day moving average price is $18.70. Healthpeak Properties has a twelve month low of $15.70 and a twelve month high of $22.95.

Healthpeak Properties (NYSE:DOC) last announced its earnings results on Tuesday, August 4th. The real estate investment trust reported $0.08 EPS for the quarter, topping the consensus estimate of $0.03 by $0.05. Healthpeak Properties had a return on equity of 2.61% and a net margin of 7.73%.The company had revenue of $771.58 million for the quarter, compared to analysts’ expectations of $725.64 million. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. Equities analysts expect that Healthpeak Properties will post 1.75 earnings per share for the current fiscal year.

Healthpeak Properties Dividend Announcement

The business also recently disclosed a monthly dividend, which will be paid on Friday, September 25th. Shareholders of record on Monday, September 14th will be issued a dividend of $0.1017 per share. The ex-dividend date of this dividend is Monday, September 14th. This represents a c) dividend on an annualized basis and a yield of 5.7%. Healthpeak Properties’s dividend payout ratio is currently 381.25%.

Insiders Place Their Bets

In other Healthpeak Properties news, insider Scott R. Bohn sold 10,989 shares of the business’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $19.45, for a total value of $213,736.05. Following the completion of the transaction, the insider directly owned 7,636 shares of the company’s stock, valued at approximately $148,520.20. The trade was a 59.00% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 0.23% of the company’s stock.

Institutional Trading of Healthpeak Properties

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Integrated Wealth Concepts LLC boosted its position in Healthpeak Properties by 7.3% in the 1st quarter. Integrated Wealth Concepts LLC now owns 18,084 shares of the real estate investment trust’s stock valued at $366,000 after buying an additional 1,231 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in shares of Healthpeak Properties by 110.3% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 121,881 shares of the real estate investment trust’s stock valued at $2,463,000 after acquiring an additional 63,930 shares during the period. Woodline Partners LP lifted its stake in shares of Healthpeak Properties by 41.3% during the first quarter. Woodline Partners LP now owns 59,103 shares of the real estate investment trust’s stock valued at $1,195,000 after acquiring an additional 17,279 shares during the period. Brown Advisory Inc. boosted its holdings in Healthpeak Properties by 3.1% in the second quarter. Brown Advisory Inc. now owns 46,770 shares of the real estate investment trust’s stock valued at $819,000 after acquiring an additional 1,415 shares during the last quarter. Finally, Qube Research & Technologies Ltd bought a new position in Healthpeak Properties in the second quarter valued at about $3,117,000. Institutional investors and hedge funds own 93.57% of the company’s stock.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.